This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
E16.3
Hospital discharge: ICD-9
2514
Cause of death: ICD-10
E16.3
Cause of death: ICD-9
2514
2 out of 7 registries used, show all original rules.
13
Check minimum number of events None
13
Include endpoints None
13
Remove individuals based on genotype QC
13
E4_GLUCAGONPLUS
Control definitions
Control exclude
E4_GLUCOPANCREAS
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E16
Name in latin
Hypersecretio glucagoni
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Increased secretion of glucagon
based on the number of shared cases.
Broader endpoints:
- Other disorders of glucose regulation and pancreatic internal secretion
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13 | 6 | 7 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
| Mean age at first event (years) | 43.87 | 49.01 | 39.47 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_GLUCAGONPLUS – Increased secretion of glucagon
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Increased secretion of glucagon
↥Endpoint not on priority list, no data to show.